Similar Efficacy and Safety of Basaglar (R) and Lantus (R) in Patients with Type 2 Diabetes in Age Groups (< 65 Years, >= 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study

Pollom, RK; Costigan, T; Lacaya, LB; Ilag, LL; Hollander, PA

Pollom, RK (reprint author), Eli Lilly & Co, Indianapolis, IN 46285 USA.

DIABETES THERAPY, 2018; 9 (2): 827

Abstract

Introduction: To compare efficacy and safety of Basaglar (R) [insulin glargine 100 units/mL; LY insulin glargine (LY IGlar)] to Lantus (R) [insulin gl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索